US › Healthcare

Masimo Corporation (MASI)

US · Healthcare · Medical Devices

$179.950.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$403.6M
Revenue YoY
+8.5%
Net profit
$57.1M
Profit YoY
+133.5%
EPS
$1.09
EPS estimate
$1.21
Net margin
14.1%

EPS came in at 1.09 against a street estimate of 1.21 — a miss of 9.9%.

Key statistics

Market cap
$9.42B
P/E
44.4
Forward P/E
40.8
P/B
11.95
Book value
$15.06
EPS (TTM)
$4.05
52-week high
$179.99
52-week low
$125.94
50-day MA
$178.69
200-day MA
$156.66
Beta
1.10

Analyst view

Analysts rate Masimo Corporation a buy (6 buy, 3 hold, 0 sell out of 9) with an average price target of $180.00.

Shareholding

Insiders
6.21%
Institutions
104.78%

Largest institutional holders

FundStake
BlackRock Inc8.87%
Politan Capital Management LP8.76%
Vanguard Group Inc8.30%
Pentwater Capital Management LP6.07%
Barclays PLC5.24%
HBK INVESTMENTS L P4.92%
Massachusetts Financial Services Company4.47%
Vanguard Capital Management, LLC3.91%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Masimo Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.